Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) FCF Margin (2025)

Centessa Pharmaceuticals has reported FCF Margin over the past 1 years, most recently at 381.64% for Q1 2025.

  • Quarterly FCF Margin changed N/A to 381.64% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 1293.75% through Dec 2025, changed N/A year-over-year, with the annual reading at 1294.59% for FY2025, N/A changed from the prior year.
  • FCF Margin was 381.64% for Q1 2025 at Centessa Pharmaceuticals.
  • Over five years, FCF Margin peaked at 381.64% in Q1 2025 and troughed at 381.64% in Q1 2025.